Bonviva 150mg tablet is a medication used to treat and prevent osteoporosis in postmenopausal women. The active ingredient in Bonviva is ibandronate sodium, which belongs to a class of drugs called bisphosphonates.
Ibandronate sodium works by slowing down the activity of osteoclasts, which are cells that break down bone tissue. By reducing the rate at which bone tissue is broken down, Bonviva helps to increase bone density and reduce the risk of fractures in postmenopausal women with osteoporosis.
Bonviva 150mg tablets are typically taken orally, once a month, on an empty stomach. It is important to follow the instructions provided by a healthcare professional when taking this medication, as taking it with food or other medications may reduce its effectiveness.
Common side effects of Bonviva may include nausea, diarrhea, stomach pain, and headache. Rarely, this medication can cause serious side effects such as severe bone, joint, or muscle pain, jaw problems, or an increased risk of thigh bone fractures. It is important to talk to a healthcare professional about the potential benefits and risks of this medication before taking it, especially if you have a history of kidney problems or digestive disorders.